Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men

Journal of Internal Medicine

Volumn 262, Issue 3, 2007, Pages 351-359

  Hergens, M P ^a   Alfredsson, L ^a,b   Bolinder, G ^c   Lambe, M ^a   Pershagen, G ^a,b   Ye, W ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Case fatality; Cohort; Myocardial infarction; Relative risk; Swedish moist snuff

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY RISK; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; ORGANIZATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SMOKELESS TOBACCO;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING; SWEDEN; TOBACCO, SMOKELESS;

EID: 34547829743     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01816.x     Document Type: Article

References (33)

1. Public Health Report (Sweden). Stockholm: National Board of Health and Welfare, 2001.
2. Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) 1992 108: 507 11.
3. Fant RV, Henningfield JE, Nelson RA, Pickworth WB. Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tob Control 1999 8: 387 92.
4. Westman EC. Does smokeless tobacco cause hypertension South Med J 1995 88: 716 20.
5. Rohani M, Agewall S. Oral snuff impairs endothelial function in healthy snuff users. J Intern Med 2004 255: 379 83.
6. Bolinder G, de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens 1998 11: 1153 63.
7. Bolinder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J Intern Med 1992 232: 327 34.
8. Bolinder G, Noren A, Wahren J, De Faire U. Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest 1997 27: 427 33.
9. Eliasson M, Lundblad D, Hagg E. Cardiovascular risk factors in young snuff-users and cigarette smokers. J Intern Med 1991 230: 17 22.
10. Siegel D, Benowitz N, Ernster VL, Grady DG, Hauck WW. Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health 1992 82: 417 21.
11. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994 84: 399 404.
12. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005 16: 347 58.
13. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes BMJ 1992 305: 1252 6.
14. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999 34: 1784 90.
15. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology 2005 16: 12 16.
16. Rosen M, Alfredsson L, Hammar N, Kahan T, Spetz CL, Ysberg AS. Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95. Results from the national AMI register in Sweden. J Intern Med 2000 248: 159 64.
17. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997 145: 72 80.
18. Shoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982 69: 239 41.
19. Eliasson M, Asplund K, Evrin PE, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 1995 113: 41 53.
20. Tucker LA. Use of smokeless tobacco, cigarette smoking, and hypercholesterolemia. Am J Public Health 1989 79: 1048 50.
21. Bolinder G, Noren A, de Faire U, Wahren J. Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis 1997 132: 95 103.
22. Benowitz NL, Porchet H, Sheiner L, Jacob P Jr. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988 44: 23 28.
23. Yashima M, Ohara T, Cao JM et al. Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction. Am J Physiol Heart Circ Physiol 2000 278: H2124 33.
24. Ohara T, Yashima M, Hamzei A et al. Nicotine increases spatiotemporal complexity of ventricular fibrillation wavefront on the epicardial border zone of healed canine infarcts. J Cardiovasc Pharmacol Ther 1999 4: 121 7.
25. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther 1997 2: 291 8.
26. Benowitz NL. Sodium intake from smokeless tobacco. N Engl J Med 1988 319: 873 4.
27. Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004 15: 252 63.
28. Rundlöf T, Olsson E, Wiernik A et al. Potential nitrite scavengers as inhibitors of the formation of N-nitrosamines in solution and tobacco matrix systems. J Agric Food Chem 2000 48: 4381 8.
29. Rouse BA. Epidemiology of smokeless tobacco use: a national study. NCI Monogr 1989 8: 29 33.
30. Schei E, Fonnebo V, Aaro LE. Use of smokeless tobacco among conscripts: a cross-sectional study of Norwegian army conscripts. Prev Med 1990 19: 667 74.
31. Wickholm S, Galanti MR, Soder B, Gilljam H. Cigarette smoking, snuff use and alcohol drinking: coexisting risk behaviours for oral health in young males. Community Dent Oral Epidemiol 2003 31: 269 74.
32. Rimm E. Alcohol and cardiovascular disease. Curr Atheroscler Rep 2000 2: 529 35.
33. Donaldson SI, Dent CW, Sussman S, Stoddard JL, Severson HH. The organizational implications of smokeless tobacco use in the lumber mill industry. Addict Behav 1996 21: 259 67.